<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Could a Generic Zocor ''Hurt'' The Statin Market?</title><link>http://articles.mercola.com/sites/articles/archive/2006/01/17/could-a-generic-zocor-hurt-the-statin-market.aspx</link><description>A generic version of Zocor, the second best selling drug in the U.S. , could result in consumers paying a good deal less for cholesterol pills. Zocor loses its patent protections in June, meaning a cheaper generic copy of the currently pricey drug may</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator><item><title>re: Could a Generic Zocor ''Hurt'' The Statin Market?</title><link>http://articles.mercola.com/sites/articles/archive/2006/01/17/could-a-generic-zocor-hurt-the-statin-market.aspx#227137</link><pubDate>Thu, 29 Oct 2009 16:43:54 GMT</pubDate><guid isPermaLink="false">24451277-a5aa-4add-96dc-64081bfd86fa:227137</guid><dc:creator>myapprentice</dc:creator><description>&lt;p&gt;This is a nice article&lt;/p&gt;
&lt;img src="http://articles.mercola.com/aggbug.aspx?PostID=227137" width="1" height="1"&gt;</description></item></channel></rss>